Elevation Wealth Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.8K Buy
54
+1
+2% +$246 ﹤0.01% 785
2026
Q2
$9.92K Buy
53
+10
+23% +$1.84K ﹤0.01% 812
2026
Q1
$8.12K Buy
43
+2
+5% +$421 ﹤0.01% 575
2025
Q4
$8.15K Hold
41
– – ﹤0.01% 520
2025
Q3
$8.32K Buy
41
+4
+11% +$710 ﹤0.01% 404
2025
Q2
$6.51K Buy
+37
New +$5.57K ﹤0.01% 391

Other funds holding THC

Elevation Wealth Partners's THC Position: Q3 2026 in Review

Elevation Wealth Partners increased its Tenet Healthcare (THC) stake by 1.9% in Q3 2026, buying an estimated $246 and bringing the position to 54 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #785.

Elevation Wealth Partners first reported a position in THC in Q2 2025 and has held it in 6 quarters since. 22 funds tracked by Wall St. Rank hold THC as of Q3 2026.

  • Elevation Wealth Partners held 54 shares of Tenet Healthcare worth $13.8K as of Q3 2026.
  • Elevation Wealth Partners bought 1 Tenet Healthcare share in Q3 2026, an estimated $246.
  • Tenet Healthcare made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #785 holding.
  • Elevation Wealth Partners first reported a position in Tenet Healthcare in Q2 2025 and has held it in 6 quarters since.
  • 22 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.